Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Benzylpenicillin Sodium
MSD Animal Health UK Limited
QJ01CE01
Benzylpenicillin Sodium
Powder for solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Horses
Antimicrobial
Expired
1990-12-05
Revised: January 2014 AN: 01162/2013 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Crystapen 5 Mega Units 3g Powder for solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE INGREDIENTS PER VIAL Benzylpenicillin 3.00g* (as Benzylpenicillin Sodium 95.7 % w/w) *equivalent to 5 mega-units of benzylpenicillin EXCIPIENTS For a full list of excipients see section 6.1 3. PHARMACEUTICAL FORM Powder for solution for Injection. White crystalline powder. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE For the treatment and control of acute and severe systemic infections caused by or associated with organisms sensitive to penicillin including: _ Arcanobacterium _ _pyogenes, _ _Erysipelothrix _ _rhusiopathiae, _ _Klebsiella _ _pneumoniae, _ _Listeria _ spp_, _ _Mannheimia haemolytica, P multocida, Proteus _ spp_, Pseudomonas aeruginosa, _ _Rhodococcus equi, Staphylococcus aureus, Streptococcus zooepidemicus,_ some _Salmonella_ spp. 4.3 CONTRA-INDICATIONS Do not use in known cases of hypersensitivity to penicillins. Do not use in small mammals (eg. gerbils, rabbits). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Penicillins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. Do not use in animals known to be sensitive to penicillin. 4.5 SPECIAL PRECAUTIONS FOR USE (I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS The usual aseptic precautions should be followed when administered the product. Not for intrathecal administration. Use of the product should be based on susceptibility testing of bacteria isolated from the animal. If this is not possible, therapy should be based on Revised: January 2014 AN: 01162/2013 Page 2 of 4 local (regional, farm level) epidemiological information about susceptibility of the target bacteria. (II) SPECIAL PRECA Read the complete document